000 | 01830 a2200529 4500 | ||
---|---|---|---|
005 | 20250517032033.0 | ||
264 | 0 | _c20150731 | |
008 | 201507s 0 0 eng d | ||
022 | _a1460-2105 | ||
024 | 7 |
_a10.1093/jnci/djv119 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLin, Chun Chieh | |
245 | 0 | 0 |
_aAndrogen deprivation with or without radiation therapy for clinically node-positive prostate cancer. _h[electronic resource] |
260 |
_bJournal of the National Cancer Institute _cJul 2015 |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 |
_aLymph Nodes _xpathology |
650 | 0 | 4 |
_aLymphatic Metastasis _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 | _aPractice Patterns, Physicians' |
650 | 0 | 4 | _aPropensity Score |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRadiotherapy Dosage |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUnited States _xepidemiology |
700 | 1 | _aGray, Phillip J | |
700 | 1 | _aJemal, Ahmedin | |
700 | 1 | _aEfstathiou, Jason A | |
773 | 0 |
_tJournal of the National Cancer Institute _gvol. 107 _gno. 7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/djv119 _zAvailable from publisher's website |
999 |
_c24884371 _d24884371 |